Novartis shipping flu vax; Sun recalls cancer drug; Ex-Pfizer exec Schulman named to Alnylam board;

@FiercePharma: Top on FiercePharmaMarketing: Facing threats from Purdue, Teva and Pfizer, Zogenix puts Zohydro follow-up into high gear. Story | Follow @FiercePharma

@TracyStaton: RT @JohnCFierce: Genentech pays $725M upfront for game-changing breast cancer drug - Seragon, spun out after Aragon deal. Article | Follow @TracyStaton

@EricPFierce: Laclede says it will alter labeling for vaginal gel products after FDA seeks injunction. More | Follow @EricPFierce

@CarlyHFierce: UPDATED: Agenus' genital herpes vax cuts viral load 75% in PhII. News | Follow @CarlyHFierce

> Novartis ($NVS) has begun shipping its Flucelvax and Fluvirin seasonal influenza vaccines to U.S. customers and says it will send a minimum of 30 million doses for the 2014-2015 season. Release

> The U.K., along with Spain and Portugal, were left out off the World Health Organization's list of 33 countries with a chance to eliminate TB altogether because their rates run too high to be included, 150 in 1 million in the U.K.'s case compared to 1 in 1 million in the U.S. Story

> Chinese drugmaker Luye Pharma Group is preparing to raise $764 million from a Hong Kong initial public offering sources tell Bloomberg. Story

> Indian drugmaker Sun Pharmaceutical's Caraco subsidiary has recalled 200 vials of the cancer drug Gemcitabine over concerns about sterility. Announcement

> Amy Schulman, the former Pfizer ($PFE) corporate counsel who suddenly departed a top spot at the drugmaker in December, has been named to the board of directors of biotech Alnylam Pharmaceuticals ($ALNY). Release

> A California judge has dismissed claims by 219 plaintiffs against GlaxoSmithKline ($GSK) who said they had heart problems tied to diabetes drug Avandia. Report

Medical Device News

@FierceMedDev: Who were the highest-paid med tech CEOs in 2013? Read up in our new report. Read | Follow @FierceMedDev

@StacyALawrence: Researchers use wearable iPad to assess multiple sclerosis symptoms. Item | Follow @StacyALawrence

@VarunSaxena2: Exec talks on Covidien's fit with Medtronic. More | Follow @VarunSaxena2

@MichaelGFierce: A tiny, "walking" robot powered by a muscle cell? It could help deliver drugs one day. More | Follow @MichaelGFierce

@EmilyWFierce: Encision nabs FDA clearance for next-generation wound-care technology. More | Follow @EmilyWFierce

> FDA clears first vital sign sensor for chairs. Story

> FDA clears device to prevent stray laproscopic surgical burns. More

> GlassesOff visual improvement app scores $15M; J&J settles hip implant suit. Article

Biotech News

@FierceBiotech: Chutes&Ladders: Former Pfizer's general counsel Schulman joins Alnylam's board. Story | Follow @FierceBiotech

@JohnCFierce: Alzheimer's R&D suffers as trial failure rate hits an "astounding" 99.6%. More | Follow @JohnCFierce

@DamianFierce: I have no idea what the next move for the Aragon/Seragon team is, but do note that Paragon Pharma is already taken. | Follow @DamianFierce

@EmilyMFierce: Acid-bath stem cell papers are finally retracted. Story via New Scientist | Follow @EmilyMFierce

> NIH readies $248M program for electroceuticals. Item

> FDA gives an early OK to lymphoma drug Beleodaq. Story

> Bind shares slide after Amgen walks out of $180M collaboration deal. More

Vaccines News

> Novartis starts shipping Flucelvax ahead of upcoming flu season. More

> Agenus brain cancer vaccine boosts survival in PhII trial. News

> Sanofi, CureVac extend vax partnership with new $205M-plus mRNA pact. Piece

> PaxVax' oral cholera vaccine succeeds in PhIII challenges. Item

> Prevnar use in seniors is cost-effective now, CDC says. But will it last? Story

> Agenus' genital herpes vax cuts viral load 75% in PhII. More

Pharma Manufacturing News

> AMRI finishes second manufacturing buy in 3 months. Read

> Pfizer recalling 221,000 bottles of Pristiq as tablet mix-up again trips it up. Piece

> Bristol-Myers recalls 6 lots of injected Coumadin. News

> FDA lays out some cGMP guidance for drug compounders. Item

> Pfizer gets access to more production capacity in Saudi Arabia with Tabuk deal. More

> FDA sues to halt production of 'unapproved' vaginal gel products. Article

And Finally... A new report says that 40% of cases in the U.K. of the highly lethal pancreatic cancer are preventable if people maintained a healthy body weight and didn't smoke. Story

Suggested Articles

AstraZeneca and Brazil have expanded their deal for a possible COVID-19 vaccine, this time to the tune of $360 million.

Novavax expects to churn out enough vaccines in 2021 to meet U.S. demand; experts slam the medical and political risks of Russia's unproven vaccine.

Novavax will have billions of doses of COVID-19 vaccine capacity next year and could single-handedly meet U.S. demand, executives said.